Beruflich Dokumente
Kultur Dokumente
This manuscript has been reproduced from the microfilm master. UMI films
the text directly from the original or copy submitted. Thus, some thesis and
dissertation copies are in typewriter face, while others may be from any type of
computer printer.
In the unlikely event that the author did not send UMI a complete manuscript
and there are missing pages, these will be noted. Also, if unauthorized
copyright material had to be removed, a note will indicate the deletion.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
THE INFLUENCES OF PERSONALITY, SOCIAL COGNITION, AND
ENVIRONMENTAL FACTORS ON PHARMACEUTICAL CARE
by
Tanattha Kittisopee
July 2001
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
UMI Number: 3018585
__ ®
UMI
UMI Microform 3018585
Copyright 2001 by Bell & Howell Information and Learning Company.
All rights reserved. This microform edition is protected against
unauthorized copying under Title 17, United States Code.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Copyright by
TANATTHA KITTISOPEE
2001
All Rights Reserved
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Graduate College
The University of Iowa
Iowa City, Iowa
CERTIFICATE OF APPROVAL
PH.D. THESIS
Tanattha Kittisopee
Thesis committee:
Member
Member
Member
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
For the Memory of My Father
"Hope you can see this success."
ii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ACKNOWLEDGMENTS
information.
My sincere gratitude is also expressed to the other
members of my committee: Dr. William R. Doucette; Dr. Julie
Ganther; and Dr. Eva Klohnen for their valuable insights
iii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
and knowledge that enabled me to fine-tune and strengthen
my thesis. I would also like to keep count of my
appreciation to Dr. John Brooks for his kindness and
knowledge provided to me during my study; to Lynn V.Borders
and Jeneva Ford for their friendships and assistance in
iv
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
have been my strength when I felt weak and my comfort in
hard times and who stepped in when I really, really needed
good friends; Arlene and John Miller who have been always
genial friends; Swalee and Dr. Cheng Saw, Asst. Prof.
Narirat and Aram Jitramontree, and my classmates who have
been sources of joy and help all the time.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
TABLE OF CONTENTS
Page
LIST OF T A B L E S ........................................... viii
LIST OF FIGURES ......................................... xii
CHAPTER
I INTRODUCTION .................................. 1
IV RESULTS....................................... 83
Descriptive Statistics .................... 84
Item Analysis and Scale Reliabilities 94
Correlations Among Variables .............. 94
Multiple Regression Analyses .............. 97
Analysis of Theoretical Model ............. 101
Mediational Analysis ...................... 103
Post Hoc A n a l y s e s ......................... Ill
Summary .................................... 132
vi
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
V D IS C U S S IO N S .................................................................................................. 136
REFERENCES............................................... 210
v ii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LIST OF TABLES
Table Page
1. The Five Factor Definitions and Illustrative
Scales ........ ............................. 18
v iii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
20. Pharmacists' Personality Characteristics
Overall Scores .................................. 88
ix
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
37. Results of Regression Model 1: Mediational
Analysis (Post Hoc Analysis) .................... 119
38. Results of Regression Model 2: Mediational
Analysis (Post Hoc Analysis) .................... 120
39. Results of Regression Model 3: Mediational
Analysis (Post Hoc Analysis) .................... 121
40. Regression Coefficient of Each Personality
Dimension Before and After Including a
Mediator (Post Hoc Analysis) .................... 122
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
50. Descriptive Statistics for Individual Items of
the Perceived Behavioral Control Measure (Item
Scale 1-7: Extremely Difficult-Extremely Easy) . 171
51. Descriptive Statistics for Individual Items of
the Behavioral Intention Measure (Item Scale
1-7: Extremely Unlikely-Extremely Likely) ..... 171
52. Descriptive Statistics for Individual Items of
the Pharmaceutical Care Provision Measure
(Scale 0-5) ...................................... 172
53. Descriptive Statistics for Individual Items of
the Adequacy of Resources Measure3 and Adequacy
of Resources Variable13.......................... 173
xi
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
64. Inter-item Correlations for the Adequacy of
Resources Measure and Adequacy of Resources
V a r i a b l e ......................................... 184
65. Structure Matrix from Factor Analysis Result
of B F I ........................................... 185
x ii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LIST OF FIGURES
Figure Page
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1
CHAPTER I
INTRODUCTION
care.
The past remarkable research (Farris, Kirking, 1995;
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
2
cognitions.
In order to facilitate the provision of pharmaceutical
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
4
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
5
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
6
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
7
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
8
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
9
CHAPTER II
LITERATURE REVIEW
Introduction
Theory-driven studies in the area of pharmacy practice
still appear limited. The pharmacy practice literature has
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
10
Personality
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
11
behavior.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
12
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
13
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
14
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
15
1999).
The second factor has been labeled with many names such
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
16
Srivastava, 1999) .
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
17
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
18
EXTRAVERSION
NEUROTICISM
OPENNESS
AGREEABLENESS
CONSCIENTIOUSNESS
Source: Pervin, L.A. John, O.P. (1996). Personality: Theory and Research 7ch edition. P
259
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
19
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
20
Robbins, 1999; Sah and Ojha, 1989; Mohan and Bali, 1988;
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
21
work performance.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
22
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
23
in Pharmacy Area
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
24
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
25
Sleath, 2000).
pharmaceutical care.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
26
Social Cognitions
Social cognitive theories emphasize the social origins
of behavior and the importance of cognitive thought
processes in all aspects of human behavior. Individuals
process information about the stimuli in the environment
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
27
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
28
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
29
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
30
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
31
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
32
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
33
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
34
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
35
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
36
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
37
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
38
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
39
care.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
40
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
41
Forgas, 1984) .
Any omitted variables that influence both the outcome
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
42
Proposition Statements
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
43
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Hypothesized Models
Extraversion
Conscientiousness
Agreeableness
Pharmaceutical
Care Provision
Openness
Neuroticism
-Practice Setting
-Workload
-Adequacy of Resources
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
45
Personality
Attitude
Perceived
Behavioral
Control
-Practice Setting
-Workload
-Adequacy of Resources
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
46
Personality
Intention
Pharmaceutical
Care Provision
Perceived
Behavioral
Control
-Practice Setting
-Workload
-Adequacy of Resources
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
47
Personality
Intention Pharmaceutical
Care Provision
Perceived
Behavioral
Control
-Practice Setting
-Workload
-Adequacy of Resources
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
48
CHAPTER III
METHODOLOGY
Research Design
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
49
Personality:
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
50
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
51
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 4. Items for Measuring Agreeableness
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
53
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
54
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
55
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
56
The score of each activity ranged from zero for none of the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
57
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
58
Behavioral Intention
Behavioral intention is one of the concepts in the
Theory of Planned Behavior. The Theory of Planned Behavior
posits that behavioral intentions are a measure of
likelihood that a person will engage in a given behavior
(Ajzen and Fishbein, 1980). The list of items used to
Figure 5.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
59
Table 10. The total behavioral intention score was the sum
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
60
Attitude toward
Pharmaceutical Care Provision
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
61
problem on a typical day during the next two weeks will make
me feel..." on a seven-point bad/good, unpleasant/pleasant,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
62
Subjective Norm
Subjective norm is the social level determinant of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
63
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
64
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
65
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
66
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
67
Practice Environment
Pharmacy practice environmental components emphasized
in the present study consisted of three factors: type of
practice setting, pharmacist's workload, and adequacy of
Table 14. Item and Answer Choices for Measuring the Type
of Practice Setting
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
68
Workload
The number of prescriptions dispensed per day by a
pharmacist can directly reflect the workload of pharmacists
which, if heavy, will prevent him from providing
pharmaceutical care. A single item was used to measure the
Adequacy of Resources
As mentioned earlier, the adequacy of resources such as
space, computer system, trained personnel, and pharmacist's
skills can facilitate the provision of pharmaceutical care.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
69
1.An area in the pharmacy where you can counsel or talk with
patients in private or semi-private manner (your
conversations cannot be easily overheard by other
individuals).
Demographic Characteristics
Background information to describe the pharmacist
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
70
Sample Frame
Sample Size
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
71
Pretest
The questionnaire was pretested by asking several
Pilot Test
The pilot test was- conducted to obtain an estimate of
the response rate and to guide in developing the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
72
Data Collection
card was sent to those who did not return the questionnaire
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
73
Data Analysis
Descriptive Analysis
in this study.
Reliability Analysis
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
74
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
75
question as
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
76
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
77
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
78
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
79
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
80
Consci = Conscientiousness
PBC = Perceived behavioral control
Work = Workload
Resour = Adequacy of resources
Setl, Set2, Set3, Set4, Set5 = Dummy
variables for the 6 types of
practice setting.
2. Regressing the pharmaceutical care score on both
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
81
Consci = Conscientiousness
PBC = Perceived behavioral control
Work = Workload
Resour = Adequacy of resources
Setl, Set2, Set3, Set4, Set5 = Dummy
variables for the 6 types of
practice setting.
For the mediational model, three regression equations
Mediator
(Behavioral Intention)
Independent Dependent
Variable Variable
(Personality) (behavior)
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
82
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
83
CHAPTER IV
RESULTS
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
84
Descriptive Statistics
Response Rate
60.14 percent.
Demographic Characteristics
The practice characteristics of the respondents are
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
85
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
86
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 19. Pharmacist Demographic Characteristics
Gender
Male 52.9
Female 47.1
Race
White/Caucasian 98.2
Black/African American 0.3
Oriental/Asian 1.2
Other 0.3
Degree earned
BS 89.4
PharmD (1st degree) 7.4
PharmD (post B.S.) 4.7
Pharmacy Residency 2.6
MS 2.1
MBA 2.4
PhD 0.6
Other 4.7
Marital Status
Single (never married) 7.4
Single (separated/divorced) 4 .4
Married 86.4
Widowed 1.8
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
88
Personality Characteristics
Pharmacists' personalities as assessed by the Five-
norm.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
89
3.5
Scile Score
2 .5 -{
1.5 ■
-RxFemale j
-RxMaJe !
Female j
-Male
0 .5 -j
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
90
Pharmacist Population
(age 25-85) (age 25-65)a t d
Mean S.D. Mean S.D.
Extraversion Female 3.40 .72 3.25 .89 -2.09 -0.17
Male 3.39 .68 3.12 .89 -4.22 -0.31
Agreeableness Female 4.04 .47 3.86 .66 -3.52 -0.28
Male 4.03 .43 3.67 .73 -6. 64 -0.50
Conscientiousness Female 4.29 .40 3.77 .70 -9.25 -0.73
cn
00
1
Male 4.07 .49 3.64 .73 -0.59
Neuroticism Female 2.56 .61 3.09 .87 7. 60 0.60
Male 2.45 .58 2.80 .88 5.40 0.40
Openness Female 3.39 .54 3.89 .69 9.06 0.72
Male 3.53 .51 3.97 .66 9.09 0.68
t = t statistic
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
91
Variables Characteristics
presented in Appendix A.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
92
a scale: 1-21
b scale: 0-55
per hour.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
93
a
scale: number of prescriptions per hour
scale: 1-24
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
94
items.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
95
Extraversion 0.8740
Neuroticism 0.7985
Agreeableness 0.7588
Openness 0.7960
Conscientiousness 0.7981
Workload -
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
96
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
97
The larger the values of VIF, the more troublesome are the
independent variables. Some people prefer to consider
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 25. Pearson Correlation Coefficient Matrix of All Study Key Variables
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
1.Extraversion 1
2.Neuroticism -.30** 1
3.Aqreeableness .22“ -.43“ 1
11.Workload -.04 .12 .02 .10 .07 .04 .05 .05 .04
©
1
12.Adequacy of .25“ -.12* .18“ .22“ .09 .29** .30“ .42** .32“ .32“ -.01 1
resources
13.Community .12* -.05 .14** -.05 .11* -.01 -.09 .00 .01 -.17“ .17** .08 1
pharmacy
14.Hospital Pharmacy -.09 .04 -.10 .03 -.14* -.01 .07 -.04 -.01 .13* -.05 .09 -.71** 1
15.Other setting -.06 .02 -.08 .03 .02 .04 .05 .05 .00 .09 -.19“ .01 -.56** -.18“ 1
**p<0.01; *p<0.05
vo
oo
99
had condition indices greater than 100, but there were two
ill-conditioned problem.
Residual values were plotted versus predicted values
in Table 26.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
100
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
101
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
102
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
103
Mediational Analysis
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
104
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
105
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
106
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
107
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
108
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
109
R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.
110
Regression Coefficient(P)
without behavioral with behavioral
intention intention
B 3 B 3
Extraversion 1.878* .106* 1.359 .076
Neuroticism 1.293 .061 .195 .009
Openness 1.071 .046 .997 .042
Agreeableness .410 .014 -.816 -.028
Conscientiousness 1.908 .070 1.904 .069
* p < 0.005
Perceived
Behavioral
Control
-Practice Setting
-Workload
-Adequacy of Resources
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Ill
Predictive Model
from All Key Variables
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
112
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
113
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
114
Full Model
with Pharmacist Demographics
To explore the contribution of pharmacist demographics
in pharmaceutical care provision, pharmacist demographic
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
115
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
116
B SE P t Sig. Collinearity
Statistics
Tolerance VIF
(Constant) -11.759 9.938 -1.183 .238
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
117
B SE P t Sig. Collinearity
Statistics
Tolerance VIF
Other position 4.192 2.291 .089 1.830 .068 1.222
.818
BS degree -.670 2.555 -.017 -.262 .793 .478 2.093
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
118
Mediator Between
Openness and
Pharmaceutical Care Provision
The result from the first research question in the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
119
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
120
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
121
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
122
* p < 0.005
Behavioral
Intention
-Practice Setting
-Workload
-Adequacy of Resources
* p<0.005
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
123
was staff and employee pharmacists. The last group was other
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
124
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
125
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
126
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
127
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
128
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
129
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
130
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
131
Variable B .
SE P 4
Sig Collinearity
Statistics
Tolerance VIF
Constant -14.986 10.301 -1.455 .147
(intercept)
Extraversion 1.845 .950 .104 1. 942 .053 .780 1.281
Neuroticism 1.476 1.215 .069 1.215 .226 .689 1.451
Openness 1.450 1.248 .062 1.162 .246 .795 1.258
Agreeableness .244 1.655 .008 .147 .883 .704 1.421
Conscientious 1.869 1.484 .068 1.260 .209 .763 1.311
ness
Perceived. 1.437 .150 .525 9. 602 .000 .748 1.337
behavioral
control
Workload 0.076 .071 .053 1.070 .286 .913 1.095
Adequacy of .298 .162 .101 1.836 .068 .729 1.371
resources
community -8.151 1.858 -.256 -4.388 .000 .652 1.534
pharma cry-
other setting -5.236 2.950 -.103 -1.775 .077 .655 1.526
Number of years 0.041 .059 .039 .695 .487 .713 1.402
licensed as a
pharmacist
Gender 1.514 1.4 65 .060 1. 033 .302 .662 1.510
Manager or 1.605 1.325 .063 1.212 .227 .819 1.221
director/assis
tant /associate/
supervisor
Other position 4 .852 2.434 .103 1. 993 .047 .835 1.197
Model R2 = 0.432; Adjusted R2 = 0.401
F = 13.878, 14 and 255 df, p = .000, n = 269
Dependent variable: Pharmaceutical care provision
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
132
Summary
Pharmaceutical care provision was the behavior of
interest in this study. Environmental factors always
influence professional behavior like the provision of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
133
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
134
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
135
Adequacy of Resources
*p<0.01
**P<0.05
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
136
CHAPTER V
DISCUSSIONS
Overview
This study had three objectives: 1) to investigate
pharmacists'' personality in predicting pharmacists' behavior
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
137
analysis.
The implications of the current study can be summarized
as the following: 1) openness, a dimension of personality,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
138
Contribution of Personality
to Pharmaceutical Care Provision
The results partially supported the hypothesis that
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
139
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
140
about the idea they encounter. They are able to grasp new
ideas and enjoy doing so" (McCrae, Costa, 1997). Openness
usually is characterized by intellect and unconventionality.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
141
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
142
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
143
they are more concerned with other people and the world
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
144
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
145
Francis and Robbins, 1999; Sah and Ojha, 1989; Anand, 1977;
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
146
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
147
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
148
Planned Behavior.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
149
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
150
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
151
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
152
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
153
position, and degree earned, were also added into the model
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
154
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
155
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
156
Scientific Implications
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
157
professional behavior.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
158
-Practice Implications
The study findings supported the partial contribution
of personality in predicting pharmaceutical care behavior.
The influences of social cognitions on pharmaceutical care
provision were stronger than personality was. Environmental
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
159
Limitations
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
160
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
161
same numbers were circled for all questions, did exist and
resulted in high correlation among these social cognition
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
162
even if it is important.
Future Research
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
163
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
164
investigation.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
165
Conclusion
This study provided insight into the interface between
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
166
pharmaceutical care.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
167
APPENDIX A
DESCRIPTIVE DATA OF ITEMS
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
168
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
169
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
170
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
171
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
172
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
173
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
174
APPENDIX B
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
175
1 2 3 4 5
1 .Talkative 1
2 .Reserved(r) .51** 1
6 7 8 9
1 .Talkative
2 .Reserved(r)
3.Full of energy
4.Enthusiasm
5 .Quiet(r)
6 .Assertive 1
7.Shy(r) .45** 1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
176
1 2 3 4 5
l.Find fault(r) 1
6 7 8 9 10
l.Find fault(r)
2 .Helpful & unselfish
3.Quarrels(r)
4.Forgiving
5.Trusting
6 .Cold(r) 1
7.Considerate .31** 1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
177
1 2 3 4 5
1. Thorough job 1
2 .Careless(r) .41** 1
6 7 8 9 10
1 .Thorough job
2 .Careless(r)
3.Reliable
4.Disorganized(r)
5.Lazy(r)
6 .Persevere 1
7.Efficient .34** 1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
178
1 2 3 4 5
1 .Depressed 1
2 .Relaxed(r) .25** 1
6 7 8 9
1 .Depressed
2. Relaxed(r)
3.Tense
4 .Worries
5.Emotionally
stable(r)
6 .Moody 1
7 .Clam(r) .23** 1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
179
1 2 3 4 5
1 .Original 1
2 .Curious .28** 1
6 7 8 9 10 11
1 .Original
2 .Curious
3.Ingenious
4.Imagination
5.Inventive
6 .Aesthetic 1
experiences
7.Prefers routine .04 1
work(r)
8 .Play with ideas .24** .24** 1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
180
1 2 3 4
1 .Attitude: patient assessment 1
activities
2 .Attitude: drug-related .57** 1
resolution activities
3. Attitude: documentation .41** .54** 1
activities
4 .ATTITUDE .80** .77** .78** 1
** Correlation is significant at the 0.01 level (2-tailed).
1 2 3 4
1 .Subjective norm: patient 1
assessment activities
2 .Subjective norm: drug-related .63** 1
resolution activities
3.Subjective norm: documentation .48** .61** 1
activities
4.SUBJECTIVE NORM .82** .79** .78** 1
** Correlation is significant at the 0.01 level (2-tailed).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
181
1 2 3 4
1 .Perceived behavioral control: 1
patient assessment
2 .Perceived behavioral control: .57** 1
drug-related resolution
activities
3.Perceived behavioral control: .40** .55** 1
documentation activities
4.PBC .79** .81** .78** 1
** Correlation is significant at the 0 . 0 1 level 2 -tailed).
1 2 3 4
1 .Intention: patient assessment 1
activities
2 .Intention: drug-related .50** 1
resolution activities
3.Intention: documentation .43** .55** 1
activities
4.INTENTION .81** .79 .78 1
** Correlation is significant at the 0.01 level (2-tailed).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
182
1 2 3 4 5 6
1 .Assess actual 1
patterns of
medication use
2 .Find out drug-related .67** 1
problems
3.Find out about .65** .65** 1
effectiveness of
takinq druq
4.Ascertain therapeutic .58** .65** .80** 1
objective
5.Identify drug-related .18** .19** .2 2 ** .2 0 ** 1
problems
6 .Implementing a .17** .19** .15** .2 0 ** .67** 1
strategy for drug-
related problems
7.Following-up .28** .29** .24** .27** .58** .69**
resolving plan for
drug-related
problems
8 .Documenting patient's .28** .27** .16** .23** .18** .2 1 **
medical condition
9.Documenting all .23** .17** .16** .23** .19** .23**
currently
medications
1 0 .Documenting drug- .28** .30** .18** .2 0 ** .31** .35**
related problems
1 1 .Documenting any .28** .33** .19** .2 0 ** .35** .38**
intervention
12.PHARMACEUTICAL CARE .62** .65** .59** .60** .53** .56**
PROVISION
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
183
7 8 9 10 11 12
1. Assess actual
patterns of
medication use
2 .Find out drug-related
problems
3.Find out about
effectiveness of
taking drug
4.Ascertain therapeutic
objective
5.Identify drug-related
problems
6 .Implementing a
strategy for drug-
related problems
7.Following-up 1
resolving plan for
drug-related
problems
8 .Documenting patient's .30** 1
medical condition
9.Documenting all .32** .58** 1
currently
medications
1 0 .Documenting drug- .44** .51** .36** 1
related problems
1 1 .Documenting any .45** .56** .43** .83** 1
intervention
12.PHARMACEUTICAL CARE .63** .64** .58** .6 8 ** .73** 1
PROVISION
Correlation is significant at the 0.01 level (2-tailed).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
184
1 2 3 4 5
1 .Private area 1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
185
Component
1 2 3 4 5
1 .Talkative .779 .131 .005 -.023 .166
2 .Find fault(r) .054 .007 .007 -.579 .463
3.Thorough -job .008 .202 .695 .021 .202
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
186
Component
1 2 3 4 5
29.Moody -.194 -.094 -.145 .616 -.418
30.Aesthetic experiences .147 .478 -.039 -.076 .210
31.Shy(r) .770 .165 .245 -.381 .111
32.Considerate .153 .168 .189 -.108 .694
33.Efficient .173 .180 .708 -.125 .136
34.Clam(r) -.101 -.412 -.288 .528 -.251
35.Prefers routine work(r) .229 .363 .098 -.205 -.083
36.Sociable .771 .208 .087 -.253 .245
37.Rude(r) .125 .080 .278 -.261 .642
38.Makes plans .232 .293 .633 -.226 .259
39.Nervous easily -.315 -.193 -.319 .644 -.050
40.Play with ideas .073 .697 .110 -.058 .096
41.Artistic interest(r) .118 .498 .045 -.091 .101
42.Coorperative .177 .248 .266 .018 .494
43.Easily distracted(r) .032 -.006 .569 -.275 -.028
44 .Sophisticated in art .052 .4 62 .021 -.041 .088
Extraction Method: Principal Component Analysis.
Rotation Method: Promax with Kaiser Normalization^
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
187
APPENDIX C
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
188
Thank you fo r participating in this study. Your responses can help us to understand patient-oriented care. You m ay w rite
comments in the margin i f needed.
1. Please check one item that best describes your employment setting.
O C om m unity Pharm acy (indcp./sm all chain) (# prescriptio ns/da y:___________)
Q C om m unity Pharm acy (cha in , >10 units) (# pre scriptio ns/da y:___________)
O C lin ic Pharm acy (# prescriptio ns/da y:___________)
O H ospital Pharm acy (# beds:___________________ )
O N ursing Hom e/Long T e rm Care (# pa tients/day:_______________)
O O th e r (de scribe ):________________________ (# patients/day o r U prescriptions/day :______________ )
2. I f you have ownership (equity) in your pharmacy, please note the extent o f your ownership:___________ %
I. Please indicate how you see yourself. W e realize that some questions are hard to answer; however, please do the best you can to
make an accurate rating (Place one o f the S numbers that applies to you on the line next to each statement).
For example, I f you strongly agree that you are talkative, place num ber S on the line next to the statement.
1. 5 is talkative
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
189
T h in k about the last five patients o f yours who presented a re fill prescription used to treat a chronic condition such as
asthma, diabetes, o r hypertension. Please indicate how many o f these five patients you provided the follow ing activities.
(Scale: 0-5, please put the number in the blank in fro n t o f the question).
1. Asking the patient questions to assess actual patterns o f use o f the m edication.
2._________ Asking the patient questions to fin d out i f he o r she m ight be experiencing drug-related problems.
3 ._________ Asking the patient questions to fin d out about the perceived effectiveness o f drugs he o r she was
taking.
4 ._________ Asking the patient questions to ascertain whether the therapeutic objective(s) was(were) being
reached.
Questions 5-8 refer to patients who presented a re fill prescription used to treat a chronic condition such as
asthma, diabetes, o r hypertension. Patient assessment activities mean four activities from questions 1-4
above.
5. M y opinion about performing a ll o f the above patient assessment activities fo r one o f m y patients in the
next 2 weeks is: (circle the number that apply to you)
Extremely Unfavorable 1 2 3 4 5 6 7 Extrem ely Favorable
6. M ost people who are important to me th in k I should perform a ll o f the above patient assessment
activities fo r one o f my patients in the next 2 weeks.
Extrem ely Disagree 1 2 3 4 5 6 7 Extrem ely Agree
7. For me, perform ing all o f the above patient assessment activities fo r one o f m y patients in the next 2
weeks is:
Extremely D iffic u lt 1 2 3 4 5 6 7 Extrem ely Easy
8. I intend to perform all o f the above patient assessment activities fo r one o f m y patients in the next 2
weeks.
Extremely U nlikely 1 2 3 4 5 6 7 Extrem ely Likely
Now, th in k about the last five patients o f yours who you discovered were experiencing drug-related
problems. Please indicate how many o f these five patients you provided the follow ing activities.
Questions 12-15 refer to patients who you discovered were experiencing chug-related problems. Drug-
related problem activities mean three activities from questions 9-11 above.
12. M y opinion about performing all o f the above drug-related resolution activities fo r one o f my patients in
the next 2 weeks is:
Extremely Unfavorable 1 2 3 4 5 6 7 Extrem ely Favorable
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
190
13. M ost people who are im portant to me th in k I should perform all o f the above.
drug-related resolution activities fo r one o f m y patients in the next 2 weeks.
Extrem ely Disagree 1 2 3 4 5 6 7 Extremely Agree
14. For me, perform ing a ll o f the above drug-related resolution activities fo r one o f
m y patients in the next 2 weeks is:
Extrem ely D iffic u lt 1 2 3 4 5 6 7 Extrem ely Easy
IV . D o c u m e n ta tio n A c t iv itie s :
Next, th in k about the last five patients o f yours who presented a prescription fo r new
medications used to treat a chronic condition such as asthma, diabetes, or
hypertension. Please indicate how many o f these fiv e patients you provided the
follow ing activities.
16. ______Docum enting inform ation about the patient’s medical conditions on w ritten records o r computerized
notes o r by other formal mechanisms in a form that could be read and interpreted b y another health
care practitioner in your absence.
17.______ Docum enting a ll medications currently being taken by the patient on the w ritten records o r
com puterized notes or by other form al mechanisms in a form that could be read and interpreted by
another health care practitioner in you r absence.
Now, th in k about the last five patients o f yours who you discovered were experiencing drug-related
problems. Please indicate how many o f these fiv e patients you provided the follow ing activities.
18.______ Docum enting the drug-related problem s, potential o r actual, on w ritten notes.
19.______ Docum enting any intervention made on the patient's profile, prescription, report, o r m edical order in
a form tha t could be read and interpreted by another health care professional.
Questions 20-23 refer to patients who presented a prescription fo r new medications used to treat a chronic
condition such as asthma, diabetes, o r hypertension o r who you discovered were experiencing drug-related
problems. Docum entation activities mean the fo u r a ctivities from questions 16-19 above.
20. M y opinion about perform ing a ll o f the above documentation activities fo r one o f m y patients in the next
2 weeks is:
Extrem ely Unfavorable 1 2 3 4 5 6 7 Extrem ely Favorable
21. M ost people w ho are important to me th in k I should perform all o f the above documentation activities
fo r one o f m y patients in the next 2 weeks.
Extrem ely Disagree 1 2 3 4 5 6 7 Extremely Agree
22. For me, perform ing a ll o f the above docum entation activities fo r one o f my patients in the next 2 weeks
is:
Extrem ely D iffic u lt 1 2 3 4 5 6 7 Extremely Easy
N ext Page
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
191
23. I intend to perform a ll o f the above documentation activities fo r one o f m y patients in the next 2 weeks.
Extrem ely U n lik e ly 1 2 3 4 5 6 7 Extremely Likely
V. Practice E n viro n m e n t:
I. The average number o f prescriptions you personally are involved w ith (dispensing/ consulting on) during a workday:
_R i's in a ho u r day
( N u m b e r o f p r e s c r ip t io n s ) ( N u m b e r o f h o u rs /d a y )
2. T his section asks about the adequacy o f resources in the pharmacy where you work to help perform pharmaceutical
care activities. Please use the fo llo w in g scale to rate the adequacy o f each type o f resource (Scale 1-6).
a) _____ A n area in the pharmacy where you can counsel o r ta lk w ith patients in private o r sem i-private manner
(yo u r conversations cannot be easily overbeard by other individuals).
b) _______ A com puter system which helps you store patient data and screen fo r drug-related problems.
c) _______ A com puter system which helps you develop patient care plans and evaluate outcomes.
d) _____ Trained pharmacy personnel that can perform some o f your tasks so that you can spend more tim e on
pharm aceutical care activities.
e) _____ Y o u r s k ills to provide pharmaceutical care services
V I. B a c k g ro u n d In fo r m a tio n :
7. W hat are the county & Z ip code o f the c ity where you have your prim ary place o f employment:
C o u n t y _________________________ Z i p _________________________
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
192
A P P R O V E D B Y IR B -0 1 (B io m e d ic a l)
IR B ID N o .: 2 0 0 0 1 1 0 5 4
A P P R O V A L D A T E : 11/280000
E X P IR A T IO N D A T E : 11/280001
T h e u n iv e r s it y o f Io w a
November 2000
«First» «Last»
«Address 1»
«Address2»
«City», «State» «ZIP»
Dear Pharmacist:
As you know, the pharmacy profession is moving toward providing more patient-oriented care. We are
studying the effects o f the pharmacist’s personal style and the environment on their decisions to provide patient-
oriented care. The results o f this study can contribute directly to the profession o f pharmacy by designing
programs and systems that better fit practices. We are looking for ways to help our profession meet the needs o f
society. Your input can guide professional organizations to establish educational programs to facilitate your
provision o f patient-oriented care. The University o f Iowa College o f Pharmacy would like to invite you to
participate in a scientific research study.
You are one o f 50 people selected by chance from the pharmacists who live in Iowa to represent
pharmacists in Iowa. You w ill receive a survey questionnaire within 7 days after receiving this letter.
A t that time, you can respond anonymously to the questionnaire by erasing the number on the back o f
the form. The fact that you participated at all will be confidential. No one in this study w ill be identified
individually.
I would be happy to send you a summary o f the results, so please let me know i f you would like them. I
hope you w ill find this study interesting.
Sincerely
College of Pharmacy Division of Clinical and Administrative Pharmacy S S 1 5 P H A R Iowa City. Iowa 52242-1112 319/335-8838 FAX 319/353-5646
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
193
A P P R O V E D B Y IR B -0 1 (B io m e d ica l)
IR B ID N o .: 2 0 0 0 1 1 0 5 4
A P P R O V A L D A T E : 11/28/2000
E X P IR A T IO N D A T E : 11/28/2001
T h e u n iv e r s it y o f Io w a
November 2000
«First» «Last»
«Address 1»
«Address2»
«City», «State» «ZIP»
Dear Pharmacist:
A few days ago you received a letter about our research project on the influences on patient-oriented
care. You were selected randomly from pharmacists living in Iowa. Your participation is important as you
represent a number o f pharmacists who were not selected to participate. You can respond anonymously by
erasing the number on the back o f the form. Individual responses w ill be kept in strict confidence. All
participation is voluntary. There is no penalty to anyone who decides not to participate. You may skip any
questions on the survey, which you do not wish to answer.
No one in this study w ill be identified individually and there are no known risks for participation. There
w ill be time costs for you as you take time to complete the questionnaire. Even though there is no direct benefit
to you, the results from this study can contribute to the sciences o f personality psychology, social psychology,
and pharmacy. This study w ill be the first to examine pharmacists’ personality traits and their relationship to
attitudes and practice environments, particularly as they relate to providing patient-oriented care. This study
will, therefore, directly apply to the profession of pharmacy.
Though the survey may look lengthy, it should only take about 12-15 minutes to complete. Please drop
me a note i f you want me to send you a summary o f the results o f our study.
I know your time is valued. Although I cannot pay each pharmacist to thank them for their time, you are
eligible for a drawing o f $100 Barnes & Noble bookstore gift certificate. Using the confidential ID number, it
w ill be drawn in the next 2 weeks. Please complete and return the enclosed survey to us.
Thank you for participating. Do not hesitate to contact with comments or questions: 319/335-8838; fax:
319/353-5646; E-mail: bemard-sorofman@uiowa.edu. Questions about the rights o f research subjects may be
addressed to the Human Subjects Office, 300 C M AB, The University o f Iowa, Iowa City. IA 52242, (319) 335-
6564.
Sincerely
College o f Pharmacy Division o f Clinical and Adm inistrative Pharmacy S 515 PHAR Iowa C ity. Iowa 52242*11 12 319/335-8838 F A X 319/353-5646
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
A P P R O V E D B Y IR B -0 1 ( B io m e d ic a l)
1R B ID N o .: 2 0Q 0110 S 4
A P P R O V A L D A T E : 11/28/2000
E X P IR A T IO N D A T E : 11/28/2001
Pharmacist Address
Dear C olleague
Thank you.
Bernard Sorofm an
S5 5 l PHAR
College o f Pharmacy
Io w a C ity. IA 5 2 2 4 2 -I I 12
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
195
A P P R O V E D B Y IR B -0 1 (B io m e d ic a l)
IR B ID N o .: 2 0 0 0 1 1 0 5 4
A P P R O V A L D A T E : 11/28/2000
E X P IR A T IO N D A T E : 11/28/2001
T h e u n iv e r s it y o f Io w a
December 2000
«First» «Last»
«Address 1»
«Address2»
«City», «State» «ZIP»
Dear Pharmacist:
As you know, the pharmacy profession is moving toward providing more patient-oriented care. We are
studying the effects o f the pharmacist’s personal style and the environment on their decisions to provide patient-
oriented care. The results o f this study can contribute directly to the profession o f pharmacy by designing
programs and systems that better fit practices. We are looking for ways to help our profession meet the needs o f
society. Your input can guide professional organizations to establish educational programs to facilitate your
provision of patient-oriented care. The University o f Iowa College o f Pharmacy would like to invite you to
participate in a scientific research study.
You are one of 600 people selected by chance from the pharmacists who live in Iowa to represent
pharmacists in Iowa. You w ill receive a survey questionnaire within 7 days after receiving this letter.
A t that time, you can respond anonymously to the questionnaire by erasing the number on the back of
the form. The fact that you participated at all w ill be confidential. No one in this study w ill be identified
individually.
I would be happy to send you a summary o f the results, so please let me know i f you would like them. I
hope you will find this study interesting.
Sincerely
College o f Pharmac} Divtsion o f Clinical and Adm inistrative Pharmacy S 515 PHAR Iowa City. Iowa 52242-1112 319/335-8838 F A X 319/353-5646
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
196
A P P R O V E D B Y IR B -01 (B io m e d ic a l)
IR B ID N o .: 2 0 0 0 1 1 0 5 4
A P P R O V A L D A T E : 11/20/2000
E X P IR A T IO N D A T E : 11/28/2001
T H E UNIVERSITY OF IOWA
«First» «Last»
«Address 1»
«Address2»
«City», «State» «ZIP»
Dear Pharmacist:
A few days ago you received a letter about our research project on the influences on patient-oriented
care. You were selected randomly from pharmacists living in Iowa. Your participation is important as you
represent a number o f pharmacists who were not selected to participate. You can respond anonymously by
erasing the number on the back o f the form. Individual responses w ill be kept in strict confidence. A ll
participation is voluntary'. There is no penalty to anyone who decides not to participate. You may skip any
question on the survey which you do not wish to answer.
No one in this study w ill be identified individually and there are no known risks for participation. There
will be time costs for you as you take time to complete the questionnaire. Even though there is no direct benefit
to you, the results from this study can contribute to the sciences o f personality psychology, social psychology,
and pharmacy. This study w ill be the first to examine pharmacists’ personality traits and their relationship to
attitudes and practice environments, particularly as they relate to providing patient-oriented care. This study
will, therefore, directly apply to the profession o f pharmacy.
Though the survey may look lengthy, it should only take about 12-15 minutes to complete. Please drop
me a note i f you want me to send you a summary o f the results o f our study.
1 know your time is valued. Although I cannot pay each pharmacist to thank them for their time, you are
eligible for a drawing for one o f the two $100 Bames & Noble bookstore gift certificates. Using the confidential
ID number, one w ill be drawn in the next 2 weeks and the other w ill be drawn at the end o f the study. Please
complete and return the enclosed survey to us.
Thank you for participating. Do not hesitate to contact with comments or questions: 319/335-8838; fax:
319/353-5646; E-mail: bemard-sorofman@uiowa.edu. Questions about the rights o f research subjects may be
addressed to the Human Subjects Office, 300 C M A B , The University o f Iowa. Iowa City, IA 52242, (319) 335-
6564.
Sincerely
College o f Pharmacy Division ofCltm cal and Admimsuauve Pharmacy S 515 PH AR lovva C ity. Iowa 522 42-11 12 319 /3 3 5 -8 8 3 8 FA X 319/353-5646
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
197
A P P R O V E D B Y IR B -01 (B io m a d ica l)
IR B ID N o .: 2 Q 0 0 1 1 0 5 4
A P P R O V A L D A T E : 11/28/2000
E X P IR A T IO N D A T E : 11/28/2001
Pharmacist Address
D ear Colleague
Thank you.
Bernard Sorofman
S 551 P H A R
College o f Pharmacy
Io w a C ity . IA 52242-1112
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
198
A P P R O V E D B Y IR B -0 1 (B io m e d ica l)
IR B ID N o .: 2 0 0 0 1 1 0 5 4
A P P R O V A L D A T E : 11/28/2000
E X P IR A T IO N D A T E : 11/28/2001
T H E UNIVERSITY OF IOWA
Januarv 2001
«First» «Last»
«Address 1»
«Address2»
«City», «State» «ZIP»
Dear Pharmacist:
About three weeks ago, I wrote to you seeking your input on research o f influences on patient-oriented
care. As o f today, I have not received your completed questionnaire. The large number o f questionnaires
returned is very encouraging. But, whether our results will be able to accurately represent Iowa pharmacists
depends upon you and the others who have not yet responded. Your input is critical to the validity o f the study.
I am writing to you again because of the significance o f each questionnaire. Your name was drawn by a
random sampling process. In order for information to be truly representative o f all Iowa pharmacists, it is
essential that all persons in the sample return their questionnaires.
Individual responses will be kept confidential and the results will be presented as aggregate numbers.
Though the questionnaire may look lengthy, it should take about 12-15 minutes to complete. You can respond
anonymously by erasing the number on the back o f the form or tearing it off.
Although I cannot pay each pharmacist for his/her time, there will be a random drawing for S100 Barnes
& Noble bookstore gift certificate at the end o f this study. You are eligible for this drawing. Please complete and
return the enclosed survey to us.
Thank you for participating. Do not hesitate to contact with comments or questions: 319/335-8838; fax:
319/353-5646; E-mail: bemard-sorofman@uiowa.edu. Questions about the rights o f research subjects may be
addressed to the Human Subjects Office, 300 C M A B , The University o f Iowa, Iowa City, IA 52242, (319) 335-
6564.
Sincerely
College o f Pharmacy Division o fC iin tca l and Administrative Pharmacy S 515 P H A R Iowa City. Iowa 5 2 2 4 2 -1 112 319/335-883& F A X 319/353-5646
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CODE BOOK
IN F LU E N C E S O N P H A R M A C E U T IC A L C AR E
1. Please check one item that best describes your employment setting.
O Com m unity Pharmacy (in d e p jsm a ll chain) (# prescriptions/day;__________ )
O Com m unity Pharmacy (chain, >10 units) (# prescriptions/day:__________ )
O C lin ic Pharmacy (# prescriptions/day;__________ )
O Hospital Pharmacy (# beds:____________________ )
O Nursing Home/Long Term Care (# patients/day:______________ )
O O ther (describe):_____________________ (# patients/day o r U prescriptions/day :_
2. I f you have ownership (equity) in your pharmacy, please note the extent o f your ownership:
%
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
200
L Please indicate how you see yourself. We realize that some questions are hard to answer; however,
please do the best you can to make an accurate rating (Place one o f the 5 numbers tha t applies to you on
the lin e next to each statement).
For example. I f you strongly agree that you are talkative, place number 5 on the lin e next to the
statem ent
I seemyselfassomeone who......
1. is talkative. 23. R tends to be lazy.
2. R tends to fin d fault w ith others. 24. R is em otionally stable, not easily upset.
3. does a thorough job. 25. is inventive.
4. is depressed, blue. 26. has an assertive personality.
3. is original, comes up w ith new ideas. 27. R can be cold and aloof.
6. R is reserved. 28. _ perseveres u n til the task is finished.
7. is helpful and unselfish. 29. can be moody.
8. R can be somewhat careless. 30. _ . values artistic, aesthetic experiences
9. R is relaxed, handles stress w e ll. 31. R is sometimes shy. inhibited.
10. is curious about many d iffe re n t things. 32. _ is considerate and kin d to almost everyone
11. is fu ll o f energy. 33. . ,. does things e ffic ie n tly .
12. R starts quarrels w ith others. 34. R remains calm in tense situations.
13. is a reliable worker. 35. R prefers work tha t is routine.
14. can be tense. 36. is outgoing, sociable.
15. is ingenious, a deep thinker. 37. R is sometimes rude to others.
16. generates a lo t o f enthusiasm. 38. makes plans and follow s through w ith them
17. . has a forgiving nature. 39. . . gets nervous easily.
18. R tends to be disorganized. 40. likes to reflect, play w ith ideas.
19. worries a I o l 41. R has few a rtistic interests.
20. has an active im agination. 42. likes to cooperate w ith others.
21. R tends to be q u ie t 43. R is easily distracted.
22. is generally trusting. 44. . is sophisticated in art. music, or literature.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
201
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
202
T hink about the last five patients o f yours who presented a re fill prescription used
to treat a chronic condition such as asthma, diabetes, o r hypertension. Please
indicate how many o f these fiv e patients you provided the follow ing activities.
(Scale: 0-5, please put the number in the blank in front o f the question).
1A skin g the patient questions to assess actual patterns o f use o f the medication.
2.Asking the patient questions to find out i f he o r she m ight be experiencing drug-related problems.
3 A skin g the patient questions to find out about the perceived effectiveness o f drugs he o r she was taking.
4A sking the patient questions to ascertain whether the therapeutic objective^) was(were) being reached.
Questions 5-8 refer to patients who presented a re fill prescription used to treat a
chronic condition such as asthma, diabetes, o r hypertension. Patient assessment
activities mean fou r activities from questions 1-4 above.
5. M y opinion about perform ing a ll o f the above patient assessment activities fo r one
o f m y patients in the next 2 weeks is: (circle the number that apply to you)
Extrem ely Unfavorable 1 2 3 4 5 6 7 Extrem ely Favorable
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
203
6. Most people who are important to me think I should perform all o f the above patient
assessment activities for one of my patients in the next 2 weeks.
Extremely Disagree 1 2 3 4 5 6 7 Extremely Agree
7. For me, perform ing a ll o f the above patient assessment activitie s fo r one o f m y patients in the next 2
weeks is:
Extrem ely D iffic u lt 1 2 3 4 5 6 7 Extremely Easy
8. I intend to perform a ll o f the above patient assessment activities fo r one o f m y patients in the next 2
weeks.
Extrem ely U n lik e ly 1 2 3 4 5 6 7 Extremely Likely
Now, think about the last fiv e patients o f yours who you discovered were experiencing drug-related
problems. Please indicate how many o f these five patients you provided the follow ing activities.
Questions 12-15 refer to patients who you discovered were experiencing drug-related problems.
Implementation o f therapeutic objectives and m onitoring plan a ctivitie s mean three activities from questions
9-11 above.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
204
12. My opinion about performing all of the above drug-related resolution activities
for one o f my patients in the next 2 weeks is:
Extremely Unfavorable 1 2 3 4 5 6 7 Extremely Favorable
13. M ost people who are im portant to me th in k I should perform a ll o f the above drug-related resolution
activities fo r one o f m y patients in the next 2 weeks.
Extrem ely Disagree 1 2 3 4 5 6 7 Extrem ely Agree
14. For me, perform ing a ll o f the above drue-related resolution activities fo r one o f m y patients in the
next 2 weeks is:
Extrem ely D iffic u lt 1 2 3 4 5 6 7 Extrem ely Easy
15. I intend to perform a ll o f the above drug-related resolution activities fo r one o f m y patients in the
next 2 weeks.
Extrem ely U n like ly 1 2 3 4 5 6 7 Extrem ely Likely
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
205
Next, think about the last five patients o f yours who presented a prescription fo r new medications used to
treat a chronic condition such as asthma, diabetes, o r hypertension. Please indicate how many o f these
fiv e patients you provided the fo llo w in g activities.
16. Documenting inform ation about the patient’s medical conditions on w ritten records or computerized
notes or by other form al mechanisms in a form that could be read and interpreted by another health
care practitioner in your absence.
17. Documenting a ll m edications currently being taken by the patient on the w ritten records or
computerized notes o r by other form al mechanisms in a form that could be read and interpreted by
another health care practitioner in your absence.
Now, think about the last five patients o f yours who you discovered were experiencing drug-related
problems. Please indicate how many o f these five patients you provided the follow ing activities.
Questions 20-23 refer to patients who presented a prescription fo r new medications used to treat a chronic
condition such as asthma, diabetes, o r hypertension or who you discovered were experiencing drug-
related problems. Documentation activities mean the four activities from questions 16-19 above.
20. M y opinion about perform ing a ll o f the above documentation activities fo r one o f m y patients in the
next 2 weeks is:
Extremely Unfavorable 1 2 3 4 5 6 7 Extrem ely Favorable
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
21. Most people who arc important to me think I should perform all o f the above documentation
activities for one o f my patients in the next 2 weeks.
Extremely Disagree 1 2 3 4 5 6 7 Extremely Agree
22. For me, perform ing a ll o f the above documentation activities fo r one o f m y patients in the next 2
weeks is:
Extrem ely D iffic u lt I 2 3 4 5 6 7 Extrem ely Easy
23. I intend to perform a ll o f the above documentation activities fo r one o f m y patients in the next 2
weeks.
Extrem ely U nlike ly 1 2 3 4 5 6 7 Extrem ely Likely
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
207
I . The average num ber o f prescriptions you personally are involved w ith (dispensing/ consulting on)
during a workday:
Rx’« in a _______h o u r day
(N um ber o f prescriptions) (N um ber o f hours/day)
1. This section asks about the adequacy o f resources in the pharmacy where you w ork to help perform
pharmaceutical care activities. Please use the follow ing scale to rate the adequacy o f each type o f
resource (Scale 1-6).
a) _____ An area in the pharmacy where you can counsel o r ta lk w ith patients in private o r
semi-private manner (your conversations cannot be easily overheard by other
individuals).
b) _____ A computer system w hich helps you store patient data and screen fo r drug-related
problems.
c) _____ A computer system w hich helps you develop patient care plans and evaluate
outcomes.
d) _____ Trained pharmacy personnel that can perform some o f your tasks so that you can
spend more tim e on pharmaceutical care activities.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
208
V I. B a c k g ro u n d In fo r m a tio n :
I .W h e n w e re y o u b o m ? 19 ____
2 . W h a t is y o u r g e n d e r ? O M a le O F e m a le
3 . W h a t is y o u r E t h n i c o r R a c ia l B a c k g r o u n d ?
O W h it e / C a u c a s ia n O B l a c k / A f r i c a n A m e r ic a n O H is p a n ic
O O r ie n t a l/ A s i a n O A m e r ic a n I n d i a n O O th e r
4 . W h a t a r e y o u r d e g re e s a n d / o r t r a i n in g ? ( C h e c k a l l t h a t a p p ly )
O B S O P h a rm D ( 1 s t d e g re e ) O P h a r m D ( p o s t B .S .) O P h a r m a c y R e s id e n c y
O M S O M B A O PhD O O t h e r _________________
5 . W h e n w e r e y o u f i r s t lic e n s e d a s a P h a r m a c is t? 19
6 . W h a t is y o u r m a r i t a l s ta tu s ?
O S i n g l e ( n e v e r m a r r ie d ) O S i n g l e ( s e p a r a t e d / d iv o r c e d ) O M a rr ie d O W id o w e d
7 .W h a t a re th e c o u n ty & Z ip c o d e o f th e c i t y w h e r e y o u h a v e y o u r p r im a r y p la c e o f
e m p lo y m e n t *
C o u n t y _________________________ Z i p __________________________
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
209
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
210
REFERENCES
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
211
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
212
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
213
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
214
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
215
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
216
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
217
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
218
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
219
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
220
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
221
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
222
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission
223
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
224
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.